Celcuity Completes $575M Convertible Note Offering at 40% Premium, Repays $137.5M Debt
CELC has more than doubled off its 52-week low of $11.275.
Summary
Celcuity completed an upsized $575 million convertible senior note offering with a 40% conversion premium, generating $557 million in net proceeds, and used $137.5 million to repay existing debt, significantly bolstering its financial position for upcoming clinical and commercial milestones.
Key Events · Financing and Capital Events · CELC
-
Upsized Convertible Note Offering Completed
Celcuity successfully closed an upsized public offering of $575 million aggregate principal amount of 0.250% Convertible Senior Notes due 2032, including the full exercise of the over-allotment option.
-
Significant Net Proceeds
The offering generated approximately $557.0 million in net proceeds for the company.
-
Favorable Conversion Premium
The notes were priced with an initial conversion price of $124.53 per share, representing a 40.0% premium over the stock's closing price on June 3, 2026 ($88.95).
-
Debt Repayment
The company used $137.5 million of the proceeds to fully repay and terminate an existing Amended and Restated Loan and Security Agreement, improving its balance sheet.
Analysis · CELC · Industrial Applications And Services
This 8-K announces the successful completion of an upsized $575 million convertible senior note offering, generating $557 million in net proceeds. The offering was priced at a 40% conversion premium to the stock's closing price on June 3, 2026, indicating strong investor confidence in the company's future growth despite recent stock volatility. A significant portion of the proceeds, $137.5 million, was used to repay existing debt, strengthening the balance sheet. The remaining capital will fund critical clinical trials and commercialization efforts for its lead therapeutic candidate, gedatolisib, which has an upcoming FDA PDUFA date of July 17, 2026. This financing provides substantial financial runway for Celcuity's strategic initiatives.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CELC was trading at $87.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $11.28 to $151.02. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.